Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Private Equity Strategies

Editorial

Saturday, June 22, 2013

Welcome to the June issue of Private Equity Strategies. This issue we will be featuring some new market sector coverage along with a few recent updates from stories we’ve covered before.

In a new feature - MicroCap Monitor we are looking at DelMar Pharmaceuticals, which has been making the rounds following a recent IPO. The company is gaining the attention of both private equity and alternatives investors based on recent cancer treatment trials in the US and abroad.

In our Dealmakers Q&A we speak with StoneCapital Partners to learn about community bank investing, which may be some of the cleanest assets available in the market today. An update from the Russian Direct Investment Fund features a new fund launched with the Abu Dabi Investment Company along with new interest in infrastructure.

In Regs watch we bring new you changes in regulation that may have a significant impact for private equity firms.

In Movers and Shakers Evercore Partners raises its largest fund to date for investements in Mexico. And in The Next Generation we highlight a bit of a row happening in the UK between the British Venture Capital Association and local business schools on the impact of PE investments on employment.

As always in Quick Hits we bring you the latest fund news and events. I welcome your feedback and hope you enjoy the issue and the summer season. Please send me any updates, thoughts, tips or comments.

Best,

Bailey McCann

Editor

 
This article was published in Opalesque's Private Equity Strategies our monthly research update on the global private equity landscape including all sectors and market caps.
Private Equity Strategies
Private Equity Strategies
Private Equity Strategies
Private Equity Strategies


Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its